RNAI Drug Delivery Market Key Highlights and Future Opportunities Till 2035
RNA interference (RNAi) therapeutics offer selective gene silencing capability, yet effective delivery remains a major challenge due to double-stranded RNA instability and endosomal trap risks. Advancements in lipid nanoparticles (LNPs), GalNAc (N-acetylgalactosamine) conjugates, and polymeric carrier platforms have successfully unlocked clinical and commercial viability for siRNA drug...
0 Comments 0 Shares 85 Views 0 Reviews